Milane L - Search Results

1

Technologies and Standardization in Research on Extracellular Vesicles.

Gandham S, Su X, Wood J, Nocera AL, Alli SC, Milane L, Zimmerman A, Amiji M, Ivanov AR. Gandham S, et al. Among authors: milane l. Trends Biotechnol. 2020 Oct;38(10):1066-1098. doi: 10.1016/j.tibtech.2020.05.012. Epub 2020 Jun 18. Trends Biotechnol. 2020. PMID: 32564882 Free PMC article. Review.

2

Label-free Raman spectral imaging of intracellular delivery and degradation of polymeric nanoparticle systems.

Chernenko T, Matthäus C, Milane L, Quintero L, Amiji M, Diem M. Chernenko T, et al. Among authors: milane l. ACS Nano. 2009 Nov 24;3(11):3552-9. doi: 10.1021/nn9010973. ACS Nano. 2009. PMID: 19863088

3

Nanoparticles: a promising modality in the treatment of sarcomas.

Susa M, Milane L, Amiji MM, Hornicek FJ, Duan Z. Susa M, et al. Among authors: milane l. Pharm Res. 2011 Feb;28(2):260-72. doi: 10.1007/s11095-010-0173-z. Epub 2010 May 27. Pharm Res. 2011. PMID: 20505985 Review.

4

Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.

Milane L, Duan Z, Amiji M. Milane L, et al. Mol Pharm. 2011 Feb 7;8(1):185-203. doi: 10.1021/mp1002653. Epub 2010 Nov 24. Mol Pharm. 2011. PMID: 20942457 Free PMC article.

5

Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.

Milane L, Duan ZF, Amiji M. Milane L, et al. Nanomedicine. 2011 Aug;7(4):435-44. doi: 10.1016/j.nano.2010.12.009. Epub 2011 Jan 8. Nanomedicine. 2011. PMID: 21220050 Free PMC article.

6

Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.

Milane L, Duan Z, Amiji M. Milane L, et al. Cancer Cell Int. 2011 Feb 14;11:3. doi: 10.1186/1475-2867-11-3. Cancer Cell Int. 2011. PMID: 21320311 Free PMC article.

7

Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Milane L, Ganesh S, Shah S, Duan ZF, Amiji M. Milane L, et al. J Control Release. 2011 Oct 30;155(2):237-47. doi: 10.1016/j.jconrel.2011.03.032. Epub 2011 Apr 8. J Control Release. 2011. PMID: 21497176 Free PMC article. Review.

8

Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer.

Milane L, Duan Z, Amiji M. Milane L, et al. PLoS One. 2011;6(9):e24075. doi: 10.1371/journal.pone.0024075. Epub 2011 Sep 8. PLoS One. 2011. PMID: 21931642 Free PMC article.

9

Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.

Yang X, Iyer AK, Singh A, Milane L, Choy E, Hornicek FJ, Amiji MM, Duan Z. Yang X, et al. Among authors: milane l. Pharm Res. 2015 Jun;32(6):2097-109. doi: 10.1007/s11095-014-1602-1. Epub 2014 Dec 17. Pharm Res. 2015. PMID: 25515492 Free PMC article.

10

Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.

Gao Y, Shen JK, Milane L, Hornicek FJ, Amiji MM, Duan Z. Gao Y, et al. Among authors: milane l. Curr Med Chem. 2015;22(11):1335-47. doi: 10.2174/0929867322666150209151851. Curr Med Chem. 2015. PMID: 25666804 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters